Metastatic cancer

Common Name(s)

Metastatic cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Metastatic cancer" returned 3517 free, full-text research articles on human participants. First 3 results:

FOLFOXIRI and bevacizumab for metastatic colorectal cancer.
 

Author(s): Chiara Cremolini, Fotios Loupakis, Alfredo Falcone

Journal: N. Engl. J. Med.. 2015 Jan;372(3):291-2.

 

Last Updated: 15 Jan 2015

Go To URL
Enzalutamide in metastatic prostate cancer before chemotherapy.
 

Author(s): Tomasz M Beer, Bertrand Tombal

Journal: N. Engl. J. Med.. 2014 Oct;371(18):1755-6.

 

Last Updated: 30 Oct 2014

Go To URL
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
 

Author(s): Ben Van Calster, Kirsten Van Hoorde, Lil Valentin, Antonia C Testa, Daniela Fischerova, Caroline Van Holsbeke, Luca Savelli, Dorella Franchi, Elisabeth Epstein, Jeroen Kaijser, Vanya Van Belle, Artur Czekierdowski, Stefano Guerriero, Robert Fruscio, Chiara Lanzani, Felice Scala, Tom Bourne, Dirk Timmerman,

Journal:

 

To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours.

Last Updated: 16 Oct 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Metastatic cancer" returned 349 free, full-text review articles on human participants. First 3 results:

[Clinical efficacy and safety of enzalutamide in metastatic castration-resistant prostate cancer: systematic review and meta-analysis].
 

Author(s): Valentin Brodszky, Márta Péntek, Petra Baji, Fanni Rencz, Lajos Géczi, Miklós Szûcs, Csaba Berczi, László Gulácsi

Journal: Magy Onkol. 2014 Sep;58(3):189-97.

 

Enzalutamide, abiraterone-acetate, and cabazitaxel are licensed post-docetaxel treatments of metastatic castration-resistant prostate cancer (mCRPC) in Hungary. The objectives of the study were to assess the efficacy and safety of post-docetaxel enzalutamide treatment and to compare ...

Last Updated: 27 Sep 2014

Go To URL
The AURORA initiative for metastatic breast cancer.
 

Author(s): D Zardavas, M Maetens, A Irrthum, T Goulioti, K Engelen, D Fumagalli, R Salgado, P Aftimos, K S Saini, C Sotiriou, P Campbell, P Dinh, G von Minckwitz, R D Gelber, M Dowsett, A Di Leo, D Cameron, J Baselga, M Gnant, A Goldhirsch, L Norton, M Piccart

Journal: Br. J. Cancer. 2014 Nov;111(10):1881-7.

 

Metastatic breast cancer is one of the leading causes of cancer-related mortality among women in the Western world. To date most research efforts have focused on the molecular analysis of the primary tumour to dissect the genotypes of the disease. However, accumulating evidence supports ...

Last Updated: 12 Nov 2014

Go To URL
Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives.
 

Author(s): Carmen Criscitiello, Fabrice André, Alastair M Thompson, Michele De Laurentiis, Angela Esposito, Lucia Gelao, Luca Fumagalli, Marzia Locatelli, Ida Minchella, Franco Orsi, Aron Goldhirsch, Giuseppe Curigliano

Journal: Breast Cancer Res.. 2014 ;16(2):205.

 

Determination of hormone receptor (estrogen receptor and progesterone receptor) and human epidermal growth factor receptor 2 status in the primary tumor is clinically relevant to define breast cancer subtypes, clinical outcome,and the choice of therapy. Retrospective and prospective ...

Last Updated: 16 Jul 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Metastatic Melanoma; Renal Cancer; Colorectal Cancer; Ovarian Cancer; Lung Cancer

 

Last Updated: 8 Jan 2015

Go to URL
Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
 

Status: Recruiting

Condition Summary: Advanced Cancer; Metastatic Cancer; Solid Tumors

 

Last Updated: 30 Jan 2015

Go to URL
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Pancreatic Cancer; Mesothelioma; Ovarian

 

Last Updated: 23 Jan 2015

Go to URL